Literature DB >> 23232547

Doubt about the feasibility of preemptive genotyping.

B C P Koch, R H N van Schaik, T van Gelder, R H J Mathijssen.   

Abstract

Mesh：

Year:  2012        PMID： 23232547     DOI： 10.1038/clpt.2012.191

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  4 in total

Review 1.  Preemptive Panel-Based Pharmacogenetic Testing: The Time is Now.

Authors:  Kristin W Weitzel; Larisa H Cavallari; Lawrence J Lesko
Journal:  Pharm Res       Date:  2017-05-02       Impact factor: 4.200

Review 2.  The genetics of drug-induced QT prolongation: evaluating the evidence for pharmacodynamic variants.

Authors:  Ana I Lopez-Medina; Choudhary Anwar A Chahal; Jasmine A Luzum
Journal:  Pharmacogenomics       Date:  2022-06-14       Impact factor: 2.638

Review 3.  Advancing Pharmacogenomics from Single-Gene to Preemptive Testing.

Authors:  Cyrine E Haidar; Kristine R Crews; James M Hoffman; Mary V Relling; Kelly E Caudle
Journal:  Annu Rev Genomics Hum Genet       Date:  2022-05-10       Impact factor: 9.340

Review 4.  Moving Pharmacogenetics Into Practice: It's All About the Evidence!

Authors:  Jasmine A Luzum; Natasha Petry; Annette K Taylor; Sara L Van Driest; Henry M Dunnenberger; Larisa H Cavallari
Journal:  Clin Pharmacol Ther       Date:  2021-07-07       Impact factor: 6.903
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.